This paper is a sequel of the previous studies related to the study of the biochemical evolution of someindicators on subjects with multiple myeloma. The study material of this paper consisted of blood samples collected from patients with multiple myeloma who were in different stages of evolution. In our country, from the consulted literature, it has been noticed that, although there were studies related to multiple myeloma – “Ways of signalization between the myeloma cell and the tumor microenvironment” – an important role is played by the changing evolution of somebiochemical indicators in this disease. This paper shows the results of the evolution in the evolution biochemicalparameters studied in the laboratory of “Elena Beldiman” Munici...
Multiple myeloma still remains a fatal disease. However, in the last months new biological and clini...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Multiple myeloma still remains a fatal disease. However, in the last months new biological and clini...
This paper presents the results of some biochemical parameters obtained in the laboratory of “Elen...
Multiple myeloma (MM) is a clonal proliferation of plasma cells invading the bone marrow and secreti...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma are lacking. Myeloma risk has been as...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
textabstractMultiple myeloma (MM) is a malignant plasma cell disorder that accounts for approximatel...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Multiple myeloma still remains a fatal disease. However, in the last months new biological and clini...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Multiple myeloma still remains a fatal disease. However, in the last months new biological and clini...
This paper presents the results of some biochemical parameters obtained in the laboratory of “Elen...
Multiple myeloma (MM) is a clonal proliferation of plasma cells invading the bone marrow and secreti...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma are lacking. Myeloma risk has been as...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
textabstractMultiple myeloma (MM) is a malignant plasma cell disorder that accounts for approximatel...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Multiple myeloma still remains a fatal disease. However, in the last months new biological and clini...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Multiple myeloma still remains a fatal disease. However, in the last months new biological and clini...